Literature DB >> 10333898

Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.

G Vanzetto1, S Halimi, T Hammoud, D Fagret, P Y Benhamou, D Cordonnier, B Denis, J Machecourt.   

Abstract

OBJECTIVE: We evaluated the prognostic value of an exercise stress test and thallium-201 scintigraphy for the prediction of cardiac events in selected high-risk NIDDM patients. RESEARCH DESIGN AND METHODS: NIDDM patients (n = 158, 105 men, aged 63 +/- 9 years) with two or more of the following criteria were prospectively included: age > or = 65 years, active smoking, hypertension > 160/95 mmHg, hypercholesterolemia (cholesterol > 5.70 mmol/l or LDL > 3.10 mmol/l), peripheral artery disease, abnormal rest electrocardiogram, or microalbuminuria (20-200 micrograms/min). An exercise-stress scintigraphy was performed in 77 patients able to exercise, while a dipyridamole scintigraphy was performed in 80 patients unable to exercise. Follow-up was 23 +/- 17 months. Major end points were cardiac deaths or nonfatal myocardial infarction.
RESULTS: The annual event rate was 7.31% (deaths: 8, myocardial infarction: 14). Independent predictors of events were as follows: an age > 60 (P = 0.02), an abnormal rest electrocardiogram (P = 0.02), microalbuminuria (P = 0.001), the inability to exercise (P = 0.009), and the presence of more than two defects on scintigraphy (P = 0.001). A cardiac death occurred in 1.3% of patients able to exercise versus 8.8% of patients unable to exercise (odds ratio = 6.8, P = 0.001). Among patients unable to exercise, large perfusion defects corresponded to an annual mortality rate of 22.3%. Conversely, the negative predictive value of a normal scintigraphy for the occurrence of death was 97%.
CONCLUSIONS: Inability to exercise and large perfusion defects on thallium-201 scan are major predictors of future death and myocardial infarction in high-risk NIDDM patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333898     DOI: 10.2337/diacare.22.1.19

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  28 in total

Review 1.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 2.  Cardiovascular risk assessment in type 2 diabetes mellitus.

Authors:  Ebaa Al-Ozairi; R Jan-Willem Middelbeek; Edward S Horton
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 3.  Single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes.

Authors:  Gavin L Noble; Gary V Heller
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

4.  Risk stratification in diabetic patients: a continuing challenge.

Authors:  Todd D Miller; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2009-06-18       Impact factor: 5.952

Review 5.  Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 6.  Diagnosis of CAD in patients with diabetes: who to evaluate.

Authors:  Lawrence H Young; Powell Jose; Deborah Chyun
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

7.  Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation.

Authors:  Yoshimitsu Yamasaki; Kenichi Nakajima; Hideo Kusuoka; Tohru Izumi; Atsunori Kashiwagi; Ryuzo Kawamori; Kazuaki Shimamoto; Nobuhiro Yamada; Tsunehiko Nishimura
Journal:  Diabetes Care       Date:  2010-08-19       Impact factor: 19.112

8.  Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease.

Authors:  Marco Matteo Ciccone; Artor Niccoli-Asabella; Pietro Scicchitano; Michele Gesualdo; Antonio Notaristefano; Domenico Chieppa; Santa Carbonara; Gabriella Ricci; Marco Sassara; Corinna Altini; Giovanni Quistelli; Mario Erminio Lepera; Stefano Favale; Giuseppe Rubini
Journal:  Vasc Health Risk Manag       Date:  2011-03-04

9.  Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients.

Authors:  Giampiero Giovacchini; Mario Cappagli; Stefano Carro; Sandro Borrini; Antonella Montepagani; Rossella Leoncini; Gianfranco Mazzotta; Gianmario Sambuceti; Giuliano Mariani; Duccio Volterrani; Michael J Zellweger; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-12       Impact factor: 9.236

10.  Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging.

Authors:  Abhijit Ghatak; Santosh Padala; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-05-24       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.